Shevan Silva
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
Papers in
-
- Cancer, Hypoxia, and Metabolism 12
-
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Adam V. Patterson (15 shared papers)Jeff B. Smaill (15 shared papers)Jack U. Flanagan (5 shared papers)C.J. Squire (1 shared paper)Y. Yosaatmadja (1 shared paper)James M. Dickson (1 shared paper)Mark J. McKeage (1 shared paper)Adriana Estrada‐Bernal (4 shared papers)
- Journals
- Molecular Cancer Therapeutics (4 papers)Pharmaceuticals (2 papers)Journal of Clinical Oncology (2 papers)Cancer Research (2 papers)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- New ZealandUnited StatesUnited Kingdom
In The Last Decade
Shevan Silva
18 papers receiving 348 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 78
- Oncology 137
- Pulmonary and Respiratory Medicine 154
- Cell Biology 68
- Biotechnology 23
Countries citing papers authored by Shevan Silva
This map shows the geographic impact of Shevan Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shevan Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shevan Silva more than expected).
Fields of papers citing papers by Shevan Silva
This network shows the impact of papers produced by Shevan Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shevan Silva. The network helps show where Shevan Silva may publish in the future.
Co-authors
The 25 scholars most cited alongside Shevan Silva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 108 | |
| 2 | 2020 | 71 | |
| 3 | 2014 | 32 | |
| 4 | 2013 | 30 | |
| 5 | 2012 | 30 | |
| 6 | 2016 | 17 | |
| 7 | 2018 | 16 | |
| 8 | 2015 | 14 | |
| 9 | 2021 | 7 | |
| 10 | 2015 | 6 | |
| 11 | 2015 | 6 | |
| 12 | 2015 | 4 | |
| 13 | 2022 | 3 | |
| 14 | 2023 | 3 | |
| 15 | 2019 | 3 | |
| 16 | 2016 | 2 | |
| 17 | 2013 | 1 | |
| 18 | 2019 | 1 |
About Shevan Silva
Shevan Silva is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Cell Biology, Molecular Biology and Oncology, having authored 18 papers that have together received 354 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (12 papers), Lung Cancer Treatments and Mutations (9 papers), Aldose Reductase and Taurine (7 papers), Cancer Research and Treatments (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Prenatal Substance Exposure Effects (3 papers), Cancer-related Molecular Pathways (2 papers) and Free Radicals and Antioxidants (2 papers). The work is most often cited by research in Cancer Research (78 citations), Oncology (137 citations), Pulmonary and Respiratory Medicine (154 citations), Cell Biology (68 citations) and Biotechnology (23 citations). Shevan Silva has collaborated with scholars based in New Zealand, United States and United Kingdom. Frequent co-authors include Adam V. Patterson, Jeff B. Smaill, Jack U. Flanagan, C.J. Squire, Y. Yosaatmadja, James M. Dickson, Mark J. McKeage, Adriana Estrada‐Bernal, Robert C. Doebele and Laurent Rigoreau. Their work appears in journals such as Molecular Cancer Therapeutics, Pharmaceuticals, Journal of Clinical Oncology, Cancer Research and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.